2018 Annual Meeting | C210 - Case Studies: Unusual Diagnostic and Management of Cases in Neuromuscular Disease

Date Thursday 04/26/18

Time 06:30 PM - 09:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Case Studies Program

Director(s) Anne M. Connolly, MD, FAAN

Topic(s)

Learning Objectives Participants should be familiar with the differential diagnosis, evaluation, treatment, and management of common and uncommon neuromuscular disorders, and gain an enhanced awareness of rare or unusual neuromuscular phenotypes.

CME Available 3.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Case-based, Interactive, Audience Participation

Event Timeline
06:30 PM - 09:30 PM	Speaker	Unusual Diagnostic and Management of Cases in Neuromuscular Disease Muhammad Al-Lozi, MD, Anne M. Connolly, MD, FAAN, P. James B. Dyck, MD, FAAN

Faculty Disclosures
Anne M. Connolly, MD, FAAN	Dr. Connolly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise Therapeutics. Dr. Connolly has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. Dr. Connolly has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Connolly has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Connolly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Connolly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Morphic Therapeutics.
Muhammad Al-Lozi, MD	Dr. Al-Lozi has nothing to disclose.
P. James B. Dyck, MD, FAAN	Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.